Key shareholder rights disclosures were made on December 16, 2025, involving CHINA STAR ENT (00326), BIOHEART-B (02185), and RS MACALLINE (01528).

**CHINA STAR ENT (00326)** - **Heung Wah Keung**: Long position changed from 1.64 billion shares to 1.62 billion shares (66.71% → 67.53%). - **Chen Mingying**: Long position adjusted similarly from 1.64 billion to 1.62 billion shares (66.71% → 67.53%). - **Heung Wah Keung Family Endowment Limited**: Maintained long position at 1.64 billion shares, now 1.62 billion (66.71% → 67.53%).

**BIOHEART-B (02185)** - **Wang Philip Li**: Long position increased marginally from 85.1077 million to 85.1177 million shares (36.11% unchanged). - **Winning Powerful Limited**: Long position rose slightly from 45.9256 million to 45.9356 million shares (19.49% → 19.48%).

**RS MACALLINE (01528)** Multiple entities adjusted holdings: - **Taobao Holding Limited**: Long position reduced from 67.2545 million to 57.0035 million shares (7.69% → 9.07%). - **New Retail Strategic Opportunities Fund, L.P.**: Cut long position from 37.2545 million to 27.0035 million shares (3.64% → 5.03%). - **Alibaba Group Holding Limited**: Decreased long position from 105 million to 84.007 million shares (11.33% → 14.10%).

*Note: Shareholding changes may result from corporate actions like rights issues, share consolidations, or splits. Verify with actual disclosures.*